Biomerica (BMRA) Short term Debt (2011 - 2012)
Biomerica recorded quarterly Short term Debt of $43000.0 in Q2 2012, up 266.21% quarter-over-quarter from $11742.0 in Q4 2011, and up 21.5% year-over-year from $35390.0 in Q2 2011.
Biomerica's Short term Debt history runs 2 years deep, the most recent figure standing at $43000.0 for Q2 2012.
- In Q2 2012, Short term Debt rose 21.5% year-over-year to $43000.0; the TTM figure through May 2012 stood at $43000.0 (up 21.5% YoY), while the FY2012 annual figure was $43000.0, up 21.5% from the prior year.
- Short term Debt came in at $43000.0 for Q2 2012 at Biomerica, up from $11742.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $43000.0 in Q2 2012 to a low of $11742.0 in Q4 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2012 | 43,000.00 |
| Nov 30, 2011 | 11,742.00 |
| Aug 31, 2011 | 23,664.00 |
| May 31, 2011 | 35,390.00 |